Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ISRG Intuitive Surgical	$469.88 -2.2%	$506.00	$425.00 ▼ $616.00	$168.44B	1.59	1.99 million shs	2.47 million shs
PATH UiPath	$10.88 -0.8%	$12.09	$9.38 ▼ $15.93	$5.82B	1.03	11.67 million shs	6.55 million shs
SYM Symbotic	$43.90 -1.3%	$46.52	$16.32 ▼ $64.16	$25.92B	2.06	1.99 million shs	1.20 million shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ISRG Intuitive Surgical	+0.26%	-0.39%	-6.91%	-11.47%	-0.57%
PATH UiPath	-0.36%	-0.41%	-12.33%	-11.23%	-9.58%
SYM Symbotic	-4.91%	-17.10%	-10.43%	+51.21%	+86.43%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ISRG Intuitive Surgical	4.9061 of 5 stars	4.3	3.0	4.0	4.1	2.5	1.9
PATH UiPath	3.7706 of 5 stars	4.0	3.0	0.0	2.7	4.2	0.6
SYM Symbotic	2.2635 of 5 stars	2.1	3.0	0.0	3.1	0.8	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ISRG Intuitive Surgical	2.63	Moderate Buy	$595.95	26.95% Upside
PATH UiPath	2.00	Hold	$13.83	27.20% Upside
SYM Symbotic	2.25	Hold	$42.69	-2.79% Downside

Current Analyst Ratings Breakdown

Latest ISRG, SYM, and PATH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2025	ISRG Intuitive Surgical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$615.00
8/15/2025	SYM Symbotic	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/8/2025	PATH UiPath	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
8/7/2025	SYM Symbotic	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/7/2025	SYM Symbotic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $57.00
8/7/2025	SYM Symbotic	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$54.00 ➝ $59.00
8/7/2025	SYM Symbotic	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$55.00
7/25/2025	SYM Symbotic	Arete Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/25/2025	SYM Symbotic	Arete Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$50.00
7/23/2025	ISRG Intuitive Surgical	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$547.00 ➝ $585.00
7/23/2025	ISRG Intuitive Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$575.00 ➝ $595.00

(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ISRG Intuitive Surgical	$8.35B	20.15	$7.83 per share	59.99	$50.08 per share	9.37
PATH UiPath	$1.45B	4.01	$0.03 per share	362.30	$3.33 per share	3.27
SYM Symbotic	$1.82B	14.23	$0.03 per share	1,724.29	$0.75 per share	58.55

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ISRG Intuitive Surgical	$2.32B	$7.17	65.47	61.53	5.02	28.51%	14.56%	12.93%	10/16/2025 (Estimated)
PATH UiPath	-$73.69M	-$0.12	N/A	N/A	14.40	-4.65%	-3.05%	-1.99%	9/4/2025 (Estimated)
SYM Symbotic	-$13.49M	-$0.07	N/A	89.62	N/A	-0.38%	-2.02%	-0.47%	N/A

Latest ISRG, SYM, and PATH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/4/2025	Q2 2026	PATH UiPath	$0.08	N/A	N/A	N/A	$347.36 million	N/A
8/6/2025	Q3 2025	SYM Symbotic	$0.03	-$0.05	-$0.08	-$0.05	$533.55 million	$592.12 million
7/22/2025	Q2 2025	ISRG Intuitive Surgical	$1.93	$2.19	+$0.26	$1.81	$2.35 billion	$2.44 billion
5/29/2025	Q1 2026	PATH UiPath	$0.10	$0.11	+$0.01	-$0.04	$332.17 million	$356.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
PATH UiPath	N/A	N/A	N/A	N/A	N/A
SYM Symbotic	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ISRG Intuitive Surgical	N/A	5.17	4.18
PATH UiPath	N/A	2.95	2.95
SYM Symbotic	N/A	1.08	0.98

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ISRG Intuitive Surgical	83.64%
PATH UiPath	62.50%
SYM Symbotic	N/A

Insider Ownership

Company	Insider Ownership
ISRG Intuitive Surgical	0.70%
PATH UiPath	23.19%
SYM Symbotic	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ISRG Intuitive Surgical	15,638	358.48 million	355.97 million	Optionable
PATH UiPath	3,868	535.04 million	410.96 million	Optionable
SYM Symbotic	1,650	590.49 million	586.95 million	Not Optionable

ISRG, SYM, and PATH Headlines

Recent News About These Companies

3 Robotics Stocks at the Heart of the Robotics Revolution (SYM)

...

4 hours ago | marketbeat.com

Symbotic (NASDAQ:SYM) Shares Down 6.2% - Here's Why

4 hours ago | marketbeat.com

Symbotic (NASDAQ:SYM) Shares Gap Down - Here's What Happened

August 21 at 12:46 PM | marketbeat.com

Investors Heavily Search Symbotic Inc. (SYM): Here is What You Need to Know

August 21 at 10:01 AM | zacks.com

Maria Freve Sells 2,000 Shares of Symbotic (NASDAQ:SYM) Stock

August 21 at 8:32 AM | insidertrades.com

Symbotic (NASDAQ:SYM) Stock Price Down 5.3% - Time to Sell?

August 20 at 2:02 PM | marketbeat.com

SYM vs. COHR: Which Technology Services Stock Has an Edge?

August 20 at 12:16 PM | zacks.com

5 High Short-Interest Stocks to Buy Before November (SYM)

...

August 20 at 11:47 AM | marketbeat.com

Symbotic (NASDAQ:SYM) Shares Down 3.8% on Insider Selling

August 20 at 2:35 AM | americanbankingnews.com

Symbotic (NASDAQ:SYM) Trading Down 3.8% After Insider Selling

August 19 at 11:22 AM | marketbeat.com

Symbotic Inc - Class A (sym) Stock News & Articles - 24/7 Wall St.

August 19 at 10:26 AM | 247wallst.com

AI’s Most Exciting Phase Is Just Getting Started

August 18 at 2:25 PM | banyanhill.comB

Symbotic: Deployment Headwinds Likely To Weigh On The Stock

August 18 at 10:40 AM | seekingalpha.com

Symbotic Inc. (NASDAQ:SYM) Director Todd Krasnow Sells 30,000 Shares

August 16, 2025 | marketbeat.com

Todd Krasnow Sells 30,000 Shares of Symbotic Inc. (NASDAQ:SYM) Stock

August 16, 2025 | insidertrades.com

Symbotic Inc. (NASDAQ:SYM) Director Rollin L. Ford Sells 90,000 Shares

August 15, 2025 | marketbeat.com

Symbotic (SYM) Delivers Robust Revenue Growth Despite Wider Net Loss

August 15, 2025 | insidermonkey.com

Jim Cramer Says He Wishes “Symbotic Were a Cleaner Story”

August 15, 2025 | finance.yahoo.com

Symbotic (SYM) Stock Soars 99% Over Last Quarter

August 14, 2025 | finance.yahoo.com

Which Is a Better Investment, Hillman Solutions Corp. or Symbotic Inc. Stock?

August 14, 2025 | aaii.comA

Why AI Robotics Stock Symbotic Surged 38.9% in July

August 14, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ISRG, SYM, and PATH Company Descriptions

Intuitive Surgical NASDAQ:ISRG

$469.88 -10.57 (-2.20%)

Closing price 04:00 PM Eastern

Extended Trading

$471.22 +1.35 (+0.29%)

As of 06:59 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

UiPath NYSE:PATH

$10.88 -0.09 (-0.78%)

Closing price 03:59 PM Eastern

Extended Trading

$10.88 +0.00 (+0.03%)

As of 07:01 PM Eastern

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York.

Symbotic NASDAQ:SYM

$43.90 -0.60 (-1.35%)

Closing price 04:00 PM Eastern

Extended Trading

$43.96 +0.06 (+0.14%)

As of 06:56 PM Eastern

Symbotic Inc., an automation technology company, engages in developing technologies to improve operating efficiencies in modern warehouses. The company automates the processing of pallets and cases in large warehouses or distribution centers for retail companies. Its systems enhance operations at the front end of the supply chain. The company was founded in 2006 and is headquartered in Wilmington, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time